References
  1. Huckaby L, Seese L, Hong YW et al. Concomitant Tricuspid Valve Surgery Is Beneficial at the Time of Left-Sided Valve Surgery. J Card Surg 2021 (In press).
  2. Mestres CA, Weber A. How do we follow up our patients? Reporting outcomes without complete follow-up data renders us on the weak side. J Thorac Cardiovasc Surg 2018; 155:586-587.
  3. Yilmaz O, Suri RM, Dearani JA, Sundt IIT, Daly RC, Burkhart HM et al. Functional tricuspid regurgitation at the time of mitral valve repair for degenerative leaflet prolapse: the case for a selective approach.J Thorac Cardiovasc Surg 2011; 142:608–613.
  4. Pahwa S, Saran N, Pochettino A et al. Outcomes of tricuspid valve surgery in patients with functional tricuspid regurgitation. Eur J Cardiothorac Surg2020 Nov 7:ezaa350. doi: 10.1093/ejcts/ezaa350.
  5. Veen KM, Etnel JRG, Quanjel TJM, et al. Outcomes after surgery for functional tricuspid regurgitation: a systematic review and meta-analysis. Eur Heart J Qual Care Clin Outcomes 2020; 6:10-18.
  6. Mestres CA, Suri R. Preventive tricuspid annuloplasty: When benefit justifies the risk. What else? J Thorac Cardiovasc Surg 2016; 152:1641-1642.
  7. Algarni KD, Alfonso J, Pragliola C et al. Long-term outcomes of tricuspid valve repair; the influence of the annuloplasty prosthesis. Ann Thorac Surg 2020 Nov 23:S0003-4975(20)31934-2. doi: 10.1016/j.athoracsur.2020.09.038.
  8. Koplan BA, Stevenson WG, Epstein LM, Aranki SF, Maisel WH. Development and validation of a simple risk score to predict the need for permanent pacing after cardiac valve surgery. J Am Coll Cardiol2003; 41: 795-801.
  9. Mestres CA. Discussion of Berdajs D, Schurr UP, Wagner A, Seifert B, Turina MI, Genoni M. Incidence and pathophysiology of atrioventricular block following mitral valve replacement and ring annuloplasty.Eur J Cardiothorac Surg 2008; 34:61.
  10. Jouan J, Mele A, Florens E et al. Conduction disorders after tricuspid annuloplasty with mitral valve surgery: implications for earlier tricuspid intervention. J Thorac Cardiovasc Surg 2016; 151:99-103.
  11. Mestres CA, Suri RM. Pacemaker risk associated with prophylactic tricuspid annuloplasty: Balancing beneficence and nonmaleficence. J Thorac Cardiovasc Surg 2016; 151:104-105.
  12. Taramasso M, Vanermen H, Maisano F et al. The growing clinical importance of secondary tricuspid regurgitation. J Am Coll Cardiol 2012; 59:703-710.
  13. Dreyfus GD. Functional tricuspid pathology: To treat or not to treat? That is the question. J Thorac Cardiovasc Surg 2017; 154:123-124.